Trial Profile
A trial of mirabegron in treatment of neurological overactive bladder in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 23 Dec 2015 New trial record